CD4 and melanoma: αβ T cells: Studies have shown that γδ T cells can amplify the release of IFN-γ by αβ T cells (in B16 melanoma), presenting antigens to CD4+ T cells and cross-presenting antigens with CD4+ T cells to CD8+ T cells, thereby stimulating targeted immune reactions and exerting antitumor effects [78].